Antibody-free virion titer greatly differs between hepatitis C virus genotypes

Journal of Medical Virology

Volumn 61, Issue 1, 2000, Pages 37-43

  Kimura, Yoichi ^a   Hayashida, Kazuhiro ^a   Ishibashi, Hiromi ^a   Niho, Yoshiyuki ^a   Yanagi, Yusuke ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

HVR; Immune complex; Immunoprecipitation; Interferon alfa

Indexed keywords

ALPHA INTERFERON; ANTIBODY;

ADULT; AMINO ACID SEQUENCE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; VIRION; VIRUS TITRATION;

ADULT; AMINO ACID SEQUENCE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PRECIPITIN TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, PROTEIN; VARIATION (GENETICS); VIRAL PROTEINS; VIRION;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0034112960     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200005)61:1<37::AID-JMV6>3.0.CO;2-E     Document Type: Article

References (42)

1. Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 73:1131-1141.
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
3. Enomoto N, Takada A, Nakao T, Date T. 1990. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Comm 170:1021-1025.
4. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91:7792-7796.
5. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. 1991. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Comm 175:220-228.
6. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H. 1993. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67:1953-1958.
7. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M. 1994. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 42:299-305.
8. Holland JJ, De La Torre JC, Steinhauer DA. 1992. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 176:1-20.
9. Ito T, Mukaigawa J, Zuo J, Hirabayashi Y, Mitamura K, Yasui K. 1996. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J Gen Virol 77:1043-1054.
10. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotohno K. 1992. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 22:107-123.
11. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. 1993. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 18:16-20.
12. Kato N, Nakazawa T, Mizutani T, Shimotohno K. 1995. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Comm 206:863-869.
13. Kimura Y, Hayashida K, Ishibashi H, Niho Y, Akazawa K, Yanagi Y. 1998. Attachment of hepatitis C virus to cultured cells: a novel predictive factor for successful interferon therapy. J Med Virol 56:25-32.
14. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
15. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
16. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR. 1994. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202:606-614.
17. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trepo C, Inchauspe G. 1996. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 97:845-851.
18. Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, Sallie R. 1994. Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405-1411.
19. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez, J. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distributidn. J Virol 66:3225-3229.
20. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, Kamada T. 1994. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Digest Dis Sci 39:977-982.
21. Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, Igimi H, Kamada T, Uchida K. 1995. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 108: 789-795.
22. Muller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L. 1993. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 74:669-676.
23. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. 1992. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 16:300-305.
24. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science 282:103-107.
25. Ogata N, Alter HJ, Miller RH, Purcell RH. 1991. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 88:3392-3396.
26. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, Miyakawa Y, Mayumi M. 1990. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 60 3:167-177.
27. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S. 1992a. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 190:894-899.
28. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. 1992b. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679.
29. Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. 1999. Acute hepatitis C virus structual gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol 73:2938-2946.
30. Shimizu YK, Purcell RH, Yoshikura H. 1993. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci USA 90:6037-6041.
31. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. 1994. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68: 1494-1500.
32. Shimizu YK, Igarashi H, Kiyohara T, Cabezon T, Farci P, Purcell RH, Yoshikura H. 1996. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223:409-412.
33. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Theo H, Cuypers M. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
34. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105-1113.
35. Thomssen R, Bonk S, Thiele A. 1993. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol 182:329-334.
36. Weiner AJ, Brauer MJ. Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M, Han JH. 1991. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-848.
37. Yoshioka K, Aiyama T, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Nagai Y, Kakumu S. 1997. Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a. J Infect Dis 175:505-510.
38. Zeuzem S, Schmidt JM, Lee JH, Ruster B, Roth WK. 1996. Effect on interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology 23:366-371.
39. Zeuzem S, Schmidt JM, Lee JH, Wagner M, Teuber G, Roth WK. 1998. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover. Hepatology 28:245-252.
40. Zibert A, Schreier E, Roggendorf M. 1995. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661.
41. Zibert A, Kraas W, Meisel H, Jung G, Roggendorf M. 1997. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infectious due to hepatitis C. J Virol 71:4123-4127.
42. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C. 1992. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15:382-386.